Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody

The angiopoietin (Ang)–Tie pathway has been intensely pursued as candidate second‐generation anti‐angiogenic target. While much of the translational work has focused on the ligand Ang2, the clinical efficacy of Ang2‐targeting drugs is limited and failed to improve patient survival. In turn, the orph...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:EMBO Mol Med
Päätekijät: Singhal, Mahak, Gengenbacher, Nicolas, La Porta, Silvia, Gehrs, Stephanie, Shi, Jingjing, Kamiyama, Miki, Bodenmiller, Diane M, Fischl, Anthony, Schieb, Benjamin, Besemfelder, Eva, Chintharlapalli, Sudhakar, Augustin, Hellmut G
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278563/
https://ncbi.nlm.nih.gov/pubmed/32302470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911164
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia